Literature DB >> 20889660

Moving toward DSM-5: the field trials.

Helena Chmura Kraemer, David J Kupfer, William E Narrow, Diana E Clarke, Darrel A Regier.   

Abstract

Mesh:

Year:  2010        PMID: 20889660     DOI: 10.1176/appi.ajp.2010.10070962

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Feasibility and acceptability of the DSM-5 Field Trial procedures in the Johns Hopkins Community Psychiatry Programs.

Authors:  Diana E Clarke; Holly C Wilcox; Leslie Miller; Bernadette Cullen; Joan Gerring; Lisa H Greiner; Alison Newcomer; Mellisha V McKitty; Darrel A Regier; William E Narrow
Journal:  Int J Methods Psychiatr Res       Date:  2014-02-25       Impact factor: 4.035

Review 2.  Defining psychosis: the evolution of DSM-5 schizophrenia spectrum disorders.

Authors:  Mahendra T Bhati
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

3.  Striking the (Im)Proper Balance between Scientific Advances and Clinical Utility: Commentary on the DSM-5 Proposal for Personality Disorders.

Authors:  Paul A Pilkonis; Michael N Hallquist; Jennifer Q Morse; Stephanie D Stepp
Journal:  Personal Disord       Date:  2011-01-01

4.  Initial construction of a maladaptive personality trait model and inventory for DSM-5.

Authors:  R F Krueger; J Derringer; K E Markon; D Watson; A E Skodol
Journal:  Psychol Med       Date:  2011-12-08       Impact factor: 7.723

5.  Towards the characterization and validation of alcohol use disorder subtypes: integrating consumption and symptom data.

Authors:  K M Jackson; K K Bucholz; P K Wood; D Steinley; J D Grant; K J Sher
Journal:  Psychol Med       Date:  2013-04-03       Impact factor: 7.723

6.  Identifying comorbid depression and disruptive behavior disorders: comparison of two approaches used in adolescent studies.

Authors:  Ann Vander Stoep; Molly C Adrian; Isaac C Rhew; Elizabeth McCauley; Jerald R Herting; Helena C Kraemer
Journal:  J Psychiatr Res       Date:  2012-05-08       Impact factor: 4.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.